ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 685503 Propanedinitrile, [5-amino-3,6-dicyano-1,2,4-trihydro-11b-methyl- [1]benzopyrano[2,3,4-de][1,6]naphthyridin-2-ylidene- 0.000588249147782798 0.24108135
NSC 724037 Null 0.000588249147782798 0.59463189
NSC 748913 2,3-Dehydrosarcovagine D 0.000588249147782798 0.34141742
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.000588249147782798 0.63135237
NSC 287459 Cytarabine AY 0.000588249147782811 0.54893165
NSC 295466 Null 0.000588249147782811 0.22152336
NSC 143093 Acetylkidamycin 0.000649370174092101 0.47945112
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.000649370174092101 0.60065167
NSC 2039 Bioquin 0.000649370174092101 0.41326104
NSC 382054 1H-Benzotriazolium, 6-(2,4-diamino-6-ethyl-5-pyrimidinyl)- 1-hydroxy-2-phenyl-, hydroxide, inner salt 0.000649370174092106 0.92053787
Total:151  Current:7    [First] [Prev] [Next] [Last]